The phosphatidylinositol 3-kinase-mediated production of interferon-β is critical for the lipopolysaccharide inhibition of osteoclastogenesis

Life Sciences

Volumn 83, Issue 9-10, 2008, Pages 369-376

  Lee, Youngkyun ^a   Huang, Hao ^a   Kim, Hyung Joon ^a   Park, Chul Kyu ^a   Kim, Hong Hee ^a  

^a Seoul National University   (South Korea)

Author keywords

c Fos; Inhibition; Interferon ; Lipopolysaccharide; Osteoclast; Phosphatidylinositol 3 kinase

Indexed keywords

BETA ACTIN; BETA INTERFERON; LIPOPOLYSACCHARIDE; NEUTRALIZING ANTIBODY; OSTEOCLAST DIFFERENTIATION FACTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN C FOS; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME INHIBITION; GENE OVEREXPRESSION; IN VITRO STUDY; IN VIVO STUDY; INTERFERON PRODUCTION; MACROPHAGE; MOUSE; NONHUMAN; ONCOGENE C FOS; OSTEOCLAST; OSTEOCLASTOGENESIS; OSTEOLYSIS; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; BONE MARROW CELLS; CELLS, CULTURED; INTERFERON-BETA; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; OSTEOCLASTS; PROTO-ONCOGENE PROTEINS C-FOS; RANK LIGAND;

EID: 49749131611     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2008.07.002     Document Type: Article

References (24)

1. Arai F., Miyamoto T., Ohneda O., Inada T., Sudo T., Brasel K., Miyata T., Anderson D.M., and Suda T. Commitment and differentiation of osteoclast precursor cells by the sequential expression of c-Fms and receptor activator of nuclear factor kappaB (RANK) receptors. Journal of Experimental Medicine 190 12 (1999) 1741-1754
2. Boyle W.J., Simonet W.S., and Lacey D.L. Osteoclast differentiation and activation. Nature 423 6937 (2003) 337-342
3. Fujihara M., Ito N., Pace J.L., Watanabe Y., Russell S.W., and Suzuki T. Role of endogenous interferon-beta in lipopolysaccharide-triggered activation of the inducible nitric-oxide synthase gene in a mouse macrophage cell line, J774. Journal of Biological Chemistry 269 17 (1994) 12773-12778
4. Grigoriadis A.E., Wang Z.Q., Cecchini M.G., Hofstetter W., Felix R., Fleisch H.A., and Wagner E.F. c-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling. Science 266 5184 (1994) 443-448
5. Huang H., Chang E.J., Ryu J., Lee Z.H., Lee Y., and Kim H.H. Induction of c-Fos and NFATc1 during RANKL-stimulated osteoclast differentiation is mediated by the p38 signaling pathway. Biochemical and Biophysical Research Communications 351 1 (2006) 99-105
6. Itoh K., Udagawa N., Kobayashi K., Suda K., Li X., Takami M., Okahashi N., Nishihara T., and Takahashi N. Lipopolysaccharide promotes the survival of osteoclasts via Toll-like receptor 4, but cytokine production of osteoclasts in response to lipopolysaccharide is different from that of macrophages. Journal of Immunology 170 7 (2003) 3688-3695
7. Jacobs A.T., and Ignarro L.J. Lipopolysaccharide-induced expression of interferon-beta mediates the timing of inducible nitric-oxide synthase induction in RAW 264.7 macrophages. Journal of Biological Chemistry 276 51 (2001) 47950-47957
8. Karaghiosoff M., Steinborn R., Kovarik P., Kriegshauser G., Baccarini M., Donabauer B., Reichart U., Kolbe T., Bogdan C., Leanderson T., Levy D., Decker T., and Muller M. Central role for type I interferons and Tyk2 in lipopolysaccharide-induced endotoxin shock. Nature Immunology 4 5 (2003) 471-477
9. Kim H.J., Lee Y., Chang E.J., Kim H.M., Hong S.P., Lee Z.H., Ryu J., and Kim H.H. Suppression of osteoclastogenesis by N,N-dimethyl-d-erythro-sphingosine: a sphingosine kinase inhibition-independent action. Molecular Pharmacology 72 2 (2007) 418-428
10. Lee Z.H., and Kim H.H. Signal transduction by receptor activator of nuclear factor kappa B in osteoclasts. Biochemical and Biophysical Research Communications 305 2 (2003) 211-214
11. Lee Y., Hyung S.W., Jung H.J., Kim H.J., Staerk J., Constantinescu S.N., Chang E.J., Lee Z.H., Lee S.W., and Kim H.H. The ubiquitin-mediated degradation of Jak1 modulates osteoclastogenesis by limiting interferon-{beta}-induced inhibitory signaling. Blood 111 2 (2008) 885-893
12. Mancuso G., Midiri A., Biondo C., Beninati C., Zummo S., Galbo R., Tomasello F., Gambuzza M., Macri G., Ruggeri A., Leanderson T., and Teti G. Type I IFN signaling is crucial for host resistance against different species of pathogenic bacteria. Journal of Immunology 178 5 (2007) 3126-3133
13. Nair S.P., Meghji S., Wilson M., Reddi K., White P., and Henderson B. Bacterially induced bone destruction: mechanisms and misconceptions. Infection and Immunity 64 7 (1996) 2371-2380
14. Qin H., Wilson C.A., Lee S.J., Zhao X., and Benveniste E.N. LPS induces CD40 gene expression through the activation of NF-kappaB and STAT-1alpha in macrophages and microglia. Blood 106 9 (2005) 3114-3122
15. Ryu J., Kim H.J., Chang E.J., Huang H., Banno Y., and Kim H.H. Sphingosine 1-phosphate as a regulator of osteoclast differentiation and osteoclast-osteoblast coupling. EMBO Journal 25 24 (2006) 5840-5851
16. Sing A., Merlin T., Knopf H.P., Nielsen P.J., Loppnow H., Galanos C., and Freudenberg M.A. Bacterial induction of beta interferon in mice is a function of the lipopolysaccharide component. Infection and Immunity 68 3 (2000) 1600-1607
17. Takami M., Kim N., Rho J., and Choi Y. Stimulation by toll-like receptors inhibits osteoclast differentiation. Journal of Immunology 169 3 (2002) 1516-1523
18. Takayanagi H., Kim S., Koga T., Nishina H., Isshiki M., Yoshida H., Saiura A., Isobe M., Yokochi T., Inoue J., Wagner E.F., Mak T.W., Kodama T., and Taniguchi T. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Developmental Cell 3 6 (2002) 889-901
19. Takayanagi H., Kim S., Matsuo K., Suzuki H., Suzuki T., Sato K., Yokochi T., Oda H., Nakamura K., Ida N., Wagner E.F., and Taniguchi T. RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-beta. Nature 416 6882 (2002) 744-749
20. Teitelbaum S.L. Bone resorption by osteoclasts. Science 289 5484 (2000) 1504-1508
21. Thomas K.E., Galligan C.L., Newman R.D., Fish E.N., and Vogel S.N. Contribution of interferon-beta to the murine macrophage response to the toll-like receptor 4 agonist, lipopolysaccharide. Journal of Biological Chemistry 281 41 (2006) 31119-31130
22. Toshchakov V., Jones B.W., Perera P.Y., Thomas K., Cody M.J., Zhang S., Williams B.R., Major J., Hamilton T.A., Fenton M.J., and Vogel S.N. TLR4, but not TLR2, mediates IFN-beta-induced STAT1alpha/beta-dependent gene expression in macrophages. Nature Immunology 3 4 (2002) 392-398
23. Weinstein S.L., Finn A.J., Dave S.H., Meng F., Lowell C.A., Sanghera J.S., and DeFranco A.L. Phosphatidylinositol 3-kinase and mTOR mediate lipopolysaccharide-stimulated nitric oxide production in macrophages via interferon-beta. Journal of Leukocyte Biology 67 3 (2000) 405-414
24. Zou W., and Bar-Shavit Z. Dual modulation of osteoclast differentiation by lipopolysaccharide. Journal of Bone and Mineral Research 17 7 (2002) 1211-1218